HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: First Response, DXM bills, J&J OTCs, Nu Skin record

This article was originally published in The Tan Sheet

Executive Summary

First Response Gold makes earliest detection claim; Virginia passes DXM age restriction; J&J “confident in communicating” on OTCs; Nu Skin reports record quarter, year; and more In Brief.

You may also be interested in...

FSA/HSA Coverage Tops CHPA 2014 Legislative Goals

The Consumer Healthcare Products Association’s No. 1 legislative priority in 2014 is restoring OTC coverage by flexible spending and health savings accounts, followed by a “close No. 2” goal of establishing an age requirement to buy DXM products. Other goals include protecting access to PSE products and blocking take-back programs.

J&J Will Boost OTC Marketing Once Reliable Production Returns

Johnson & Johnson CEO Alex Gorsky says he expects 75% of OTC products previously recalled to be back on the market in 2013, and the firm will begin prioritizing marketing efforts once a consistent supply of products is restored. The McNeil Fort Washington facility will remain offline another year.

DXM legislation

The "Dextromethorphan Distribution Act of 2006" (H.R. 5280) now has 13 cosponsors and has been referred to the House Committee on Energy & Commerce, the Consumer Healthcare Products Association states July 26. The bill would allow FDA to limit the distribution of the bulk ingredient to only those people or entities that are registered with the agency and would make it more difficult for teens to abuse the drug. Stephen Pasierb of the Partnership for a Drug-Free America spoke about CHPA's efforts to curb abuse of OTCs during a July 26 hearing held by the House Government Reform Subcommittee on Criminal Justice, Drug Policy & Human Resources. CHPA and the Partnership launched a public service campaign in May to inform consumers about the dangers of abusing DXM and other Rx and OTC drugs (1"The Tan Sheet" May 22, 2006, p. 4)...


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts